Navigation Links
Vanda Pharmaceuticals to Present New Data on Iloperidone at the 2007 American Society of Human Genetics Annual Meeting
Date:10/22/2007

ROCKVILLE, Md., Oct. 22 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced today that it will present five posters on the pharmacogenetics of iloperidone at the 57th American Society of Human Genetics (ASHG) annual meeting to be held in San Diego, CA, from October 23 through October 27, 2007. This announcement follows the submission of the NDA filing for iloperidone on September 27, 2007. Iloperidone is an investigational atypical antipsychotic for the treatment of schizophrenia.

The following posters will be presented on Thursday, October 25, 2007, from 4:30 p.m. to 6:30 p.m. PDT, at the San Diego Convention Center.

POSTER 1035 - Whole Genome Association Study Identifies Polymorphisms in

the NPAS3 Gene Associated with Enhanced Response to

Iloperidone Treatment in Patients with Schizophrenia

POSTER 1036 - Pharmacogenetic Study of Iloperidone Treatment in Patients

with Schizophrenia Identifies Markers Associated with

Efficacy

POSTER 1037 - Pharmacogenetic Analysis Shows Differences in Markers

Associated with Response Between Two Atypical

Antipsychotics, Iloperidone and Ziprasidone, in the

Treatment of Patients with Schizophrenia

POSTER 1039 - Whole Genome Association Study Identifies Polymorphisms in

the CERKL Gene Associated with QT Prolongation during

Iloperidone Treatment of Patients with Schizophrenia

POSTER 1040 - Single-Nucleotide Polymorphisms in the CYP2D6 Gene Are

Correlated with Iloperidone Drug Exposure Levels, Affecting


'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... 14, 2014 Many people are unhappy ... plastic surgery to reduce a “double chin.” A ... the need to go under the knife. Jawflex is ... jaw muscles, therefore tightening the skin in that area ... Jawflex is used for facial exercise, double chin elimination ...
(Date:7/14/2014)... Many diet plans often recommend eating plenty ... School of Public Health at the University of Alabama ... effect on weight loss. Now experts are suggesting that the ... of portion control to trigger measurable weight loss. ... controlling how much is consumed, simply by using a specially-designed ...
(Date:7/14/2014)... Seattle, WA (PRWEB) July 14, 2014 ... start up company Passionate Playground announces its first product ... adult pleasure product storage system. , Inventor ... for passionate consumers to have a storage solution for ... in the multibillion dollar adult retail industry. , Semer ...
(Date:7/14/2014)... 14, 2014 EurekaMag.com has newly published ... is a contagious liver disease that ranges in ... to a serious, lifelong illness that attacks the liver. ... have chronic Hepatitis C virus infection of which approximately ... research category covers all studies on Hepatitis C ...
(Date:7/14/2014)... "Medical devices, tests, and treatments are critical ... is a star when it comes to innovations in ... working on amazing products and ideas that are our ... to Dale Kaye CEO of the Innovation Tri-Valley ... brilliant minds and businesses that are leading society into ...
Breaking Medicine News(10 mins):Health News:Jawflex | Double Chin Exercise for Double Chin Reduction 2Health News:Increase Vegetable Consumption Has Zero Effect on Weight Loss – Portion Control is Recommended by Experts 2Health News:Increase Vegetable Consumption Has Zero Effect on Weight Loss – Portion Control is Recommended by Experts 3Health News:Passionate Playground launches Joyboxx 2Health News:Passionate Playground launches Joyboxx 3Health News:EurekaMag.com Publishes 64,900 New Studies on Hepatitis C 2Health News:Believing in the Possible – Innovation Tri-Valley’s Sixth Innovation Forum Examines the Tri-Valley’s Wealth of Innovators 2Health News:Believing in the Possible – Innovation Tri-Valley’s Sixth Innovation Forum Examines the Tri-Valley’s Wealth of Innovators 3Health News:Believing in the Possible – Innovation Tri-Valley’s Sixth Innovation Forum Examines the Tri-Valley’s Wealth of Innovators 4
... of its,mission to help consumers feel better and lead ... WNI ), introduces two new,products that help maintain health ... Nutrition is key to staying healthy, but sometimes the ... compounds into our bodies. Schiff(R),3-Day Cleanse is a simple ...
... To World-Class ... Knowledge-Based Economy, ... Business at,Carnegie Mellon University and its Donald H. Jones ... Pittsburgh: Building Bridges to a City,s New Future." The,symposium, ...
... Comprehensive Eating,Disorders Program at Lucile Packard Children,s Hospital ... 18 to 21. This allows the program to,now ... "I am delighted that the Eating Disorders ... group," said Naomi Brown, PhD, an eating,disorders treatment ...
... trials reported using independent safety monitoring committees that can ... reactions, according to a major review published in the ... University of Nottingham carried out a detailed analysis of ... to see what safety measures were in place to ...
... http://www.pharmacyfraudsettlement.com with filed documents, fraud, allegations, ... ... As front line professionals dispensing medications to,Medicaid beneficiaries pharmacists are particularly ... and report Medicaid fraud, which is noted in the site., ...
... Peake: VA Reaches Out to Vets, Families in ... veterans and,their families during major emergencies, especially natural ... to deploy mobile pharmacies,that will provide vital medicine ... will also open up the facilities to help ...
Cached Medicine News:Health News:Schiff(R) Introduces New Supplement Products for Intestinal Health and Beauty Maintenance 2Health News:Carnegie Mellon's Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future, March 25 2Health News:Carnegie Mellon's Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future, March 25 3Health News:Carnegie Mellon's Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future, March 25 4Health News:Carnegie Mellon's Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future, March 25 5Health News:Carnegie Mellon's Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future, March 25 6Health News:Eating Disorders Program at Lucile Packard Children's Hospital Expands to Include Young Adults 2Health News:Eating Disorders Program at Lucile Packard Children's Hospital Expands to Include Young Adults 3Health News:Only 2 percent of child drug trials have independent safety checks 2Health News:Only 2 percent of child drug trials have independent safety checks 3Health News:CVS, America's Largest Pharmacy Chain, Pays Nearly $37 Million to Settle Federal and State Generic Drug Switching Charges 2Health News:CVS, America's Largest Pharmacy Chain, Pays Nearly $37 Million to Settle Federal and State Generic Drug Switching Charges 3Health News:VA Putting Mobile Pharmacies on the Road 2
(Date:7/14/2014)... LONDON , July 14, 2014  VirtualScopics, ... (AIM: IXI) jointly announced today the formation of a ... Edward Ashton , Ph.D., chief scientific officer, VirtualScopics, ... members. "The formation of this joint Scientific ... commercial and operational alliance we signed with IXICO plc ...
(Date:7/13/2014)... -- Eli Lilly and Company (NYSE: LLY ... in genetically engineered mice examining combination therapy with ... and beta-secretase inhibitor BACE (LY2811376). Data results found ... clumps of amyloid-beta protein in the brain – ... Alzheimer,s disease (AD) – than use of one ...
(Date:7/11/2014)... , July 11, 2014 Patient ... marketing and, consequently, organizations are turning to an ... As part of this evolving approach ... to educate, communicate and engage patients throughout their ... to patient empowerment. By mapping the patient journey ...
Breaking Medicine Technology:VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 2VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 3VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 4VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 5VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 6VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 7VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 8VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 9New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2
... Calif., April 29, 2011 First Quarter ... by 321 institutions, up from 239 in Q4 2010 ... revenue Operational focus enables lower planned expense growth in ... by Astellas NGX-1998 Phase 2 clinical trial continues in ...
... Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a ... cancers and infectious diseases, announced today that the company will ... Securities Research Conference San Francisco, CA, May 9-11, 2011 ... Dr. J. Joseph Kim, Ph.D., President & CEO May ...
Cached Medicine Technology:NeurogesX Reports First Quarter 2011 Results 2NeurogesX Reports First Quarter 2011 Results 3NeurogesX Reports First Quarter 2011 Results 4NeurogesX Reports First Quarter 2011 Results 5NeurogesX Reports First Quarter 2011 Results 6NeurogesX Reports First Quarter 2011 Results 7NeurogesX Reports First Quarter 2011 Results 8Inovio Pharmaceuticals to Present at Investor Conferences 2Inovio Pharmaceuticals to Present at Investor Conferences 3Inovio Pharmaceuticals to Present at Investor Conferences 4
... Maxim knee system's curved-on-curved articulation maintains ... excellent sizing options for better patient ... alloy plasma spray porous coating, which ... own ArCom processed polyethylene is used ...
... posterior stabilized knee has an advanced ... flange mates with both resurfacing and ... precise, repeatable kinematics and fit with ... reduce wear. Constant cutting guide peg ...
... tricompartmental total knee prosthesis stems from many ... design and manufacturing technologies have been used ... as well as a favorable pressure distribution ... keep wear to a minimum. The inherent ...
The Balanced Knee System provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results....
Medicine Products: